Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    Open Studies | "Hyperlipidemias"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hyperlipidemias"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Acupuncture and Moxibustion for Hyperlipemia
Condition: Hyperlipidemias
Interventions: Other: acupuncture and moxibustion;   Drug: Simvastatin;   Other: Therapeutic Lifestyle Change
2 Recruiting Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Condition: Hyperlipidemia
Intervention: Drug: TAK-085
3 Recruiting A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
4 Recruiting Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Condition: Hyperlipidemias
Interventions: Drug: Antroquinonol;   Drug: placebo
5 Recruiting A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia
Condition: Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Other: Placebo
6 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
7 Recruiting Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: Atorvastatin 20 mg;   Drug: Cholestyramine 8 g;   Drug: Omega-3 2g;   Drug: Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg;   Behavioral: Lifestyle modification
8 Not yet recruiting Nutraceuticals to Improve Lipid Profile in European Countries
Condition: Hyperlipidemia
Interventions: Behavioral: Non-pharmacologic intervention;   Drug: Nutraceuticals (Armolipid Plus)
9 Not yet recruiting Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Condition: Hyperlipidemia
Interventions: Drug: TAK-085;   Other: Not treated with omega-3-acid ethyl esters
10 Recruiting Effect of Butter & MCT Oil on Lipoproteins - A RCT
Condition: Hyperlipidemia
Intervention: Dietary Supplement: MCT oil + Butter in Coffee
11 Recruiting Acute Microvascular Changes With LDL Apheresis
Condition: Hyperlipidemia
Intervention: Procedure: Plasmapharesis
12 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
13 Recruiting Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
Condition: Hyperlipidemias
Interventions: Drug: HCP1105;   Drug: HGP0816;   Drug: Placebo of HCP1105;   Drug: Placebo of HGP0816
14 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
15 Recruiting Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
Condition: Hyperlipidemia
Intervention: Drug: Atorvastatin
16 Not yet recruiting A Survey on the Under-treatment of hypercholeSterolemia (EPHESUS Trial)
Condition: Hyperlipidemias
Intervention:
17 Recruiting Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia
Condition: Oxidative Stress
Interventions: Dietary Supplement: XXS;   Dietary Supplement: non-XXS
18 Recruiting Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflamation Study in Patients With Elevated Lipoprotein(a) (Lp(a)).
Condition: Subjects With Hyperlipidemia, Dyslipidemia
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
19 Recruiting Chart Review of Repatha® in Subjects With Hyperlipidaemia
Condition: Hypercholesterolaemia
Intervention:
20 Recruiting The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers
Conditions: Diabetes;   Hyperlipidemia
Interventions: Drug: Metformin + Rosuvastatin;   Drug: JLP-1310

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.